SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-24-001937
Filing Date
2024-01-11
Accepted
2024-01-11 16:16:07
Documents
5
Effectiveness Date
2024-01-11

Document Format Files

Seq Description Document Type Size
1 S-8 ef20018650_s8.htm S-8 55622
2 EXHIBIT 5.1 ef20018650_ex5-1.htm EX-5.1 9798
3 EXHIBIT 23.1 ef20018650_ex23-1.htm EX-23.1 2077
4 EXHIBIT 107 ef20018650_ex107.htm EX-FILING FEES 21532
5 image0.jpg GRAPHIC 69112
  Complete submission text file 0001140361-24-001937.txt   185562
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-276471 | Film No.: 24529443
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)